MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 10-24-2023
NextGen Healthcare Book Value 2011-2026 | NXGN
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value NextGen Healthcare
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 432 M | 400 M | 376 M | 323 M | 305 M | 269 M | 284 M | 295 M | 307 M | 295 M | 225 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 432 M | 225 M | 319 M |
Quarterly Book Value NextGen Healthcare
| 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 423 M | 400 M | - | 442 M | - | 423 M | 411 M | 435 M | 439 M | 432 M | 426 M | 420 M | 404 M | 400 M | 400 M | 391 M | 381 M | 376 M | 365 M | 355 M | 337 M | 323 M | 331 M | 326 M | 314 M | 305 M | 298 M | 285 M | 270 M | 269 M | 285 M | 287 M | 280 M | 284 M | 283 M | 285 M | 291 M | 295 M | 300 M | 321 M | 310 M | 307 M | 321 M | 312 M | 307 M | 295 M | 282 M | 269 M | 251 M | 225 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 442 M | 225 M | 337 M |
Book Value of other stocks in the Health information services industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
391 M | - | 0.29 % | $ 206 M |  USA |
 |
Phreesia
PHR
|
251 M | $ 11.28 | - | $ 615 M | USA |
 |
Change Healthcare
CHNG
|
3.28 B | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
3.68 B | - | - | $ 27.9 B | USA |
 |
American Well Corporation
AMWL
|
248 M | $ 5.63 | -2.26 % | $ 90.3 M | USA |
 |
Computer Programs and Systems
CPSI
|
187 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
1.53 B | - | - | $ 2.94 B | USA |
 |
Schrödinger
SDGR
|
364 M | $ 11.4 | -1.47 % | $ 837 M | USA |
 |
iCAD
ICAD
|
28.7 M | - | - | $ 102 M | USA |
 |
Castlight Health, Inc.
CSLT
|
7.25 B | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
715 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
26.4 M | - | - | $ 6.37 B | USA |
 |
Teladoc Health
TDOC
|
1.39 B | $ 5.57 | 2.77 % | $ 982 M | USA |
 |
1Life Healthcare
ONEM
|
1.73 B | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
1.53 B | - | - | $ 2.33 B | USA |
 |
Omnicell
OMCL
|
1.24 B | $ 34.94 | 1.39 % | $ 1.61 B | USA |
 |
OptimizeRx Corporation
OPRX
|
127 M | $ 7.18 | 5.9 % | $ 123 M | USA |
 |
Evolent Health
EVH
|
859 M | $ 2.27 | 0.89 % | $ 213 M | USA |
 |
MTBC
MTBC
|
59.5 M | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
725 M | $ 2.06 | 0.98 % | $ 795 M | USA |
 |
SCWorx Corp.
WORX
|
4.49 M | $ 0.13 | 1.5 % | $ 190 K | USA |
 |
Signify Health
SGFY
|
821 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
347 M | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-7.01 M | - | - | $ 161 M | USA |
 |
Zhongchao
ZCMD
|
24.2 M | $ 1.8 | -0.55 % | $ 9.37 M |  China |
 |
Allscripts Healthcare Solutions
MDRX
|
1.41 B | - | -10.39 % | $ 886 M | USA |
 |
Health Catalyst
HCAT
|
246 M | $ 1.1 | 0.46 % | $ 76.9 M | USA |
 |
NantHealth
NH
|
-225 M | - | -46.64 % | $ 10.4 M | USA |
 |
HealthEquity
HQY
|
2.11 B | $ 82.47 | 0.45 % | $ 7.1 B | USA |
 |
HealthStream
HSTM
|
511 M | $ 21.23 | 1.24 % | $ 645 M | USA |
 |
10x Genomics
TXG
|
741 M | $ 20.91 | 5.55 % | $ 2.45 B | USA |
 |
Streamline Health Solutions
STRM
|
12.3 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-57 M | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
422 M | $ 17.75 | -1.66 % | $ 1.52 B | USA |
 |
So-Young International
SY
|
1.96 B | $ 3.19 | 9.62 % | $ 253 M | China |
 |
Veeva Systems
VEEV
|
7.21 B | $ 178.11 | -0.56 % | $ 29.2 B | USA |